• search

Ind Swift Lab secures EDQM certification for Clarithromycin

Written by: Staff

Mumbai, Mar 28 (UNI) Ind Swift Laboratories has received the EDQM (European Directorate for the Quality of Medicines) certification for its key bulk drug Clarithromycin.

This is the second significant certification which the company has received within a short span of time, a company release here said.

The certification can be used by the manufacturers of pharmaceutical products in their applications for marketing authorisation to demonstrate the compliance of the substance used, with the monographs of the European Pharmacopoeia.


For Daily Alerts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more